OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!


2006 Ann Schreiber Grant Recipient – Tsukasa Baba

Tsukasa Baba, M.D.
Duke University
Using Public Research Resources to Find New Drugs to Treat Resistant Ovarian Cancer

Project Summary

Dr. Baba’s research focuses on identifying new drugs that can be used to treat women with taxane and platinum resistant ovarian cancer. His approach is based on using a publically available database that shows the results of using 44,000 compounds to inhibit the growth 59 cancer cell lines. He will analyze the data collected on taxane and cisplatin in this database to find other drugs that might be useful in treating resistant ovarian cancer. These results are anticipated to provide a foundation for initiation of clinical trials of candidate drugs identified based on ovarian cancer-specific drug sensitivity profiles.